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Abstract 
As in a previous tudy (Biochim. Biophys. Acta 1224 (1994) 127-138), we used quantitative immunoblot analysis and found that rat 
pancreatic acini possess four different isoforms of PKC-alpha, delta, epsilon and zeta. The phorbol ester 12-O-tetradecanoyl phorbol 
13-acetate (TPA) caused translocation f each isoform from the cytosol to the membrane fraction. CCK-8 increased iacylglycerol (DAG) 
and caused translocation of PKC-8 and PKC-e but not that of PKC-a or PKC-s r. L-364,718, a CCK receptor antagonist, prevented as 
well as reversed the effects of CCK-8 on DAG and on translocation of PKC-8 and PKC-e. To explore the possibility that different 
isoforms of PKC might have. different distributions in rat pancreas, we used immunocytochemistry to determine the cellular distribution of 
different isoforms of PKC in intact pancreas as well as pancreatic acini. In intact pancreas, PKC-a and PKC-8 were detected in islet cells 
but not in duct or acinar cells. PKC-e was detected in the apical region of acinar cells and PKC-~" was detected over the luminal surfaces 
of acinar cells and the ductules that extend from the acinus. Neither PKC-e nor PKC-~" was detected in islets. In pancreatic acini PKC-a 
and PKC-8 were detected in islets or fragments of islets that contaminated the preparation but were not detected in acinar cells. PKC-e 
was detected in the apical region of acinar cells and adding 1 /,M TPA or 1 /,M CCK-8 accentuated the immunostaining but did not alter 
its cellular distribution. L-364,718 reversed the changes in immunostaining caused by CCK-8. PKC-s r was detected over the luminal 
surface of the acinar cells. TPA, but not CCK-8 or CCK-8 followed by L-364,718, increased the number of acini that showed staining of 
the luminal surfaces of acin~u" cells. Thus, the present results demonstrate that different isoforms of PKC are distributed differently in rat 
pancreas and that the different patterns of distribution can explain, at least in part, the different responses to CCK-8. 
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1. Introduction 
PKC was initially identified as a protein kinase that 
could be activated by calcium and phospholipids [1]. Sub- 
sequently it was found that PKC could be activated by 
diacylglycerol [1]. Activation of PKC has been proposed to 
be involved in a variety of cell responses including cell 
proliferation, secretion, smooth muscle contraction, regula- 
tion of gene expression ~md membrane transport [1]. Dur- 
ing the last several years it has become apparent that PKC 
is actually a family of related enzymes that are differen- 
tially expressed in various cell types [2]. Biochemical, 
immunologic and molecular cloning studies have demon- 
strated the existence of isoforms of PKC that can be 
divided into two classes based on whether or not they are 
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activated by calcium. For example, PKC isoforms ~, 131, 
/32 and 3~ are activated by calcium, and phospholipid; 
isoforms iS, E, ~" and 7/are activated by phospholipid but 
not by calcium [2]. Isoform-specific properties such as 
rates of down-regulation, subcellular location, activation 
requirements and substrate specificities uggest hat differ- 
ent isoforms may regulate unique cellular functions [2-5]. 
On the other hand, in cells that possess multiple isoforms, 
the particular function of an individual isoform has not yet 
been clearly established. Moreover, to date no endogenous 
isoform-specific substrate has been identified for any iso- 
form of PKC. 
In a previous study [6] of rat pancreatic acini using 
quantitative immunoblot analysis we detected four differ- 
ent isoforms of PKC-c~, ~, E and ft. We did not detect he 
/3, y or 7/ isoforms. We also found that although CCK-8 
caused a three-fold increase in cellular DAG, CCK-8 
caused redistribution of PKC-t5 and PKC-e but not PKC-a 
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or PKC-~" from the cytosol to the membrane fraction of 
homogenized acini. 
In our previous tudy [6] we considered the possibility 
that the isoforms whose distribution is not altered by 
CCK-8 might be in different cells from those in which the 
increase in DAG occurs. In the present study we examined 
this possibility by using immunocytochemistry to deter- 
mine the cellular distribution of different isoforms of PKC 
in intact pancreas as well as in pancreatic acini. Our results 
indicate that PKC-c~, PKC-6, PKC-E and PKC-~" are each 
distributed ifferently in the pancreas and that the pattern 
of cellular distribution can explain, at least in part, whether 
or not a particular isoform undergoes translocation in 
response to CCK-8. 
2. Materials 
Male Sprague-Dawley rats (75-150 g) were obtained 
from Harlan-Sprague-Dawley, Indianapolis, IN; purified 
collagenase (Type CLSPA, 643 units/mg) from Worthing- 
ton Biochemicals, Freehold, NJ; Hepes, TPA and soybean 
trypsin inhibitor from Sigma Chemical, St. Louis, MO; 
glutamine from Research Plus Laboratories, Danville, N J; 
COOH-terminal octapeptide of cholecystokinin (CCK-8), 
from Peninsula Laboratory, Belmont, CA; basal media 
(Eagle) amino acids (100-times concentrated) from GIBCO, 
Grand Island, NY; essential vitamin mixture (100-times 
concentrated) from Microbiological Associates, Bethesda, 
MD; bovine plasma albumin (fraction V) from Miles 
Laboratories, Elkhart, IN; rabbit polyclonal anti-PKC c~, 
/3, y, 6, e and ~" and the corresponding peptide antigens 
from GIBCO BRL, Grand Island, NY; rabbit polyclonal 
anti-PKC r/ from Sphinx Pharmaceutical Corp., Durham, 
NC; Hyperfilm MP and enhanced chemiluminescence 
(ECL) from Amersham, Arlington Heights, IL; 
poly(vinylidene difluoride) membrane sheets and goat 
anti-rabbit IgG from Bio-Rad Laboratories, Richmond, 
CA; sn-l,2-diacylglycerol kinase from Calbiochem, San 
Diego, CA; spectral grade methanol, chloroform and iso- 
propyl alcohol from EM Science, Gibbstown, NJ; and 
reagent-grade glacial acetic acid from Fisher Scientific, 
Fair Lawn, NJ. 
Unless stated otherwise, the standard incubation solu- 
tion contained 24.5 mM Hepes (pH 7.4), 98 mM NaC1, 6 
mM KC1, 2.5 mM NaH2PO 4, 5 mM sodium pyruvate, 5
mM sodium fumarate, 5 mM sodium glutamate, 0.5 mM 
CaC12, 1% (w/v)  albumin, 0.1% (w/v) trypsin inhibitor, 
1% (v/v)  essential amino acid mixture, 0.1% (w/v) baci- 
tracin and 1% (v/v)  vitamin mixture. All incubations were 
performed with 100% 02 as the gas phase. 
3. Methods 
Tissue preparation. Dispersed acini from rat pancreas 
were prepared using the modifications [7] of the procedure 
published previously [8]. 
PKC isoforms. The various isoforms of PKC were 
measured by quantitative immunoblot analysis as de- 
scribed previously [6]. Acini from six pancreata were 
suspended in 5 ml of standard incubation solution. Sam- 
ples (1 ml) were incubated for the times and with the 
agents indicated at 37°C. Values for the amount of a 
particular isoform associated with the membrane fraction 
were expressed as a percentage of the total fraction (i.e., 
cytosol plus membrane fraction). With each isoform that 
was detected the appropriate band could be abolished by 
preincubating the antiserum with the corresponding pep- 
tide antigen. The activity of each antiserum was confirmed 
by documenting its ability to detect he appropriate PKC 
isoform in supernatant prepared from rat brain homogenate 
as described previously [6]. 
Diacylglycerol (DAG). Acini from one pancreas were 
suspended in 13 ml of standard incubation solution and 1 
ml samples were incubated at 37°C for the appropriate 
time with the agents indicated. Cellular DAG was deter- 
mined using the mass assay described previously [6]. DAG 
was expressed as nmol/100 nmol phospholipid. 
Phospholipid. Phospholipid was measured using the 
phosphate assay of Ames [9] as described previously [6]. 
Immunocwtochemistry. Acini from two animals were 
centrifuged at 200 g for 10 min and after removing the 
supernatant were fixed in B5 (220 mM HgCI 2, 90 mM 
sodium acetate, 3.7% (v/v)  formaldehyde) overnight and 
paraffin blocked. Slices from intact rat pancreas (2 mm 
thick) were fixed in the same manner. Tissue sections, 4 
/zm thick, were deparaffinized in xylene, rehydrated in 
decreasing concentrations of ethanol (100%, 95%, 70% 
(v/v)) and serially incubated in Lugol's iodine solution, 
Table 1 
Effect of  CCK-8 and TPA on diacylglycerol and the distribution of  different isoforms of PKC in pancreatic acini 
Addition Diacylglycerol PKC Isoform (% membrane) 
(nmol /100  nmol phospholipid) Alpha Delta Epsilon Zeta 
None 0.21 _ 0.03 35 _ 4 10 _+ 2 16 + 3 18 _+ 3 
CCK-8 (1 /zM) 0.61 _+ 0.08 * 37_+ 5 42 _+ 4 * 77 + 8 * 17 _+ 2 
TPA(1  /xM) - 71 +3 " 68+5 * 9+7 * 74+6 * 
Pancreatic acini were incubated with the agents indicated for 10 min at 37°C. Values given are means + S.D. from 4 separate xperiments. 
* Significantly different (P  < 0.01) from corresponding value for no addition by Student's paired t-test. 
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5% (w/v) sodium thios.ulfate followed by phosphate- 
buffered saline (PBS; 20 mM sodium phosphate (pH 7.4), 
150 mM NaC1). To block non-specific binding of the 
primary antibodies, sections were incubated in blocking 
solution (10% (v/v)  calf serum, 10% (v/v)  goat serum, 
1% (w/v) poly(ethylene glycol) M r 20000, in PBS) for 
30 min. Sections were then incubated overnight with rabbit 
PKC isoform-specific antisera, diluted 1:200 ((v/v) in 
blocking solution). Samples were subsequently rinsed in 
PBS, reblocked for 15 rain and incubated in fluorescein 
isothiocyanate (FITC)-labeled goat anti-rabbit IgG (diluted 
at 1:50 in blocking solution) for 20 rain. Sections were 
rinsed in PBS and mourned in a fresh mixture of para- 
phenylenediamine (PPD (2 mg/ml))in 50% glycerol (v/v, 
in PBS). The slides were viewed using Nikon Optiphot-2 
mercury epifluorescent microscope (Nikon Incorporation, 
Instrument Group, NY, USA) and a confocal microscope 
(Bio-Rad MRC 600). 
. . . . .  ~ • . . . .  
4. Results 
CCK-8 caused a 3-fold increase in DAG in pancreatic 
acini and under identical conditions caused translocation of
PKC-6 and PKC-e but not PKC-cr or PKC-s r (Table 1). 
The phorbol ester TPA caused translocation of each of the 
four different isoforms of PKC in pancreatic acini (Table 
1). 
To examine the reversibility of the actions of CCK-8 on 
DAG and PKC-e acini were first incubated with CCK-8 
for 10 min and then with the CCK receptor antagonist 
L-364,718 for another 10 min. As illustrated in Table 2, 
the effects of CCK-8 on DAG and PKC-e were reversed 
completely within 10 min after adding L-364,718. Results 
similar to those illustrated in Table 2 for PKC-e were also 
obtained with PKC-~ (data not shown). 
We were initially puzzled by the results in Table 1 
showing that CCK-8 increased iacylglycerol but caused 
Fig. 1. Sections from rat pancreas immunostained with rabbit polyclonal antiserum against PKC-a  and PKC-6  isoenzymes. In panel A - top, PKC-a  
staining is confined to some of the peripheral islet cells, with no staining in the cells located in the center of  the islet or in the acini. Panel A - bottom 
shows that there is no staining fi)r PKC-ot over the pancreatic ducts. In panel B - top, PKC-6 has a distribution similar to that for PKC-ot in that staining 
is in some of the peripheral islet cells. Panel B - bottom shows that there is no staining for PKC-6 over the pancreatic ducts. In both panels magnif ication 
is x 400. Antiserum preabsorbed with the synthetic immunizing peptide showed no staining (data not shown). 
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Table 2 
Reversibility of the effect of 
pancreatic acini 
CCK-8 on diacylglycerol and PKC-e in 
Addition Diacylglycerol PKC-e 
(nmol/100nmol (percent 
pbospbolipid) membrane) 
None 0.22 __ 0.03 19 _+ 4 
CCK-8 (1 /zM) 0.64_+0.09 * 68_+9 * 
L-364,718 (1 /zM) 0.21 _+0.04 20_+3 
CCK-8 then L-364,718 0.26 _+ 0.05 18 _+ 4 
Pancreatic acini were incubated at 37°C with no additions, CCK-8 or 
L-364,718 for 10 min or with CCK-8 for 10 min followed by L-364,718 
for an additional 10 min. 
* Significantly different (P <0.01) from corresponding value for no 
addition by Student's paired t-test. 
translocation of  only PKC-6 and PKC-e  and not PKC-a  
or PKC-~. We considered the possibil ity that different 
isoforms of PKC might be in different cell types, thereby 
accounting for the different responses to CCK-8. To exam- 
ine this possibility, we used immunocytochemistry to de- 
termine the cellular distribution of  different isoforms of 
PKC in the pancreas. 
As illustrated in Fig. l, we detected PKC-a  and PKC-6 
A 
in some of the peripheral islet cells in sections from whole 
rat pancreas. Neither PKC isoform was detected in acinar 
cells or duct cells. Incubating 1 ~g of antibody with 
40-100  p,g of the corresponding synthetic peptide antigen 
overnight at 4°C abolished the staining of  the peripheral 
islet cells (data not shown). We also detected PKC-a  and 
PKC-6 in peripheral cells in islets or fragments of  islets 
that were present in our preparation of  pancreatic acini, but 
there was no detectable PKC-a  or PKC-6 in acinar cells 
or duct cells (data not shown). We detected no PKC-/3 in 
any preparation by immunocytochemistry (data not shown). 
PKC-e was detected in acinar cells but not in islet cells 
or duct cells in sections from rat pancreas (Fig. 2). PKC-e 
was localized to the apical region of the acinar cell (Fig. 
2B) where, on bright field microscopy, zymogen granules 
could be identified. Confocal microscopy also identified 
PKC-e in the apical region of  the acinar cells (Fig. 2C). 
Incubating 1 /~g of antibody with 10 /zg of  the PKC-e 
synthetic peptide antigen overnight at 4°C abolished subse- 
quent immunostaining for PKC-E (Fig. 2A). 
PKC-s r was detected in acinar cells and duct cells but 
not in islet cells in sections from rat pancreas (Fig. 3). 
PKC-~" was detected in the region of  the luminal surface 
of  the acinar cells as well as the luminal surface of  the 
Fig. 2. Sections from rat pancreas immunostained with rabbit polyclonal antiserum against PKC-e. In panel A - top, antiserum preabsorbed with the 
immunizing PKC-e synthetic peptide shows no specific staining (magnification is × 400). Panel A - bottom is a confocal photomicrograph s owing no 
specific staining for PKC-e when the antiserum was preabsorbed with the immunizing PKC-e synthetic peptide. In panel B - top, there is prominent 
vesicular staining confined to the apical region of the acinar cells (magnification is X400). Panel B - bottom shows that there is no staining for PKC-~ 
over the pancreatic ducts. In panel C, confocal microscopy illustrates that the staining has a vesicular pattern and is confined to the apical pole of the acinar 
cells where zymogen granules are located. In panels A - bottom and C, confocal magnification is indicated by the bar. 
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ductules that extend from the acinus (Fig. 3B). Confocal 
microscopy confirmed that PKC-¢ was present at the 
luminal surface of acinar cells and associated uctules 
(Fig. 3C). Incubating 1 /zg of antibody with 10 /zg of the 
PKC-~" synthetic peptide antigen overnight at 4°C abol- 
ished subsequent immunostaining for PKC-~" (Fig. 3A). 
In pancreatic acini (Fig. 4), as in sections of whole 
pancreas (Fig. 2), PKC-e was localized to the apical 
region of the acinar cells (Fig. 4A). Incubating the acini 
with 1 /.tM TPA (Fig. 4B) and with 1 /zM CCK-8 (Fig. 
4C) accentuated the immunostaining in the apical region of 
the acinar cells but did not change the cellular distribution 
of the immunostaining. In acini that had been incubated 
with 1 /zM CCK-8 followed by 1 /~M L-364,718, the 
intensity of the staining in the apical region of the acinar 
cell was nearly the same as that in control acini, but there 
was a more diffuse cytoplasmic distribution of the 
immunostaining (Fig. 4D). 
Fig. 4. Effects of CCK-8 and TPA on the immunostaining of PKC-e in rat pancreatic a ini. Pancreatic a ini were incubated at 37°C for 10 min with no 
additions (A), 1 /xM TPA (B), 1 /xM CCK-8 (C) or l /.tM CCK-8 for l0 rain and then l /xM L-364,718 for an additional 10 min (D). In panel A, in 
control acini there is vesicular staining predominantly localized to the apical region of the acinar cells. In panel B with TPA, and in panel C with CCK-8, 
there is accentuation of the vesicular staining in the apical region of the acinar cells. In panel D with CCK-8 followed by L-364,718, the intensity ofthe 
apical staining iscomparable to that in panel A, but the staining has a more diffuse cellular distribution than in panels A-C. In each panel magnification is 
X 400. 
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In pancreatic acini, PKC-,~ was localized to the luminal 
surface of the acinar cells (Fig. 5A). No ductule structures 
were detected in our preparation of acini, probably because 
the ductules are removed during processing whole pan- 
creas to produce dispersed acini [7,8]. Incubating acini 
with 1 /zM TPA increased the number of acini that 
showed staining at the luminal surface of the acinar cells 
(Fig. 5B). Incubating acini with 1 /zM CCK-8 (Fig. 5C) or 
1 /zM CCK-8 followed by 1 /xM L-364,718 (Fig. 5D) did 
not detectably alter the immunostaining of the acini. 
5. Discussion 
The present results demonstrate he different patterns of 
distribution of the various isoforms of PKC that can be 
detected by quantitative immunoblot analysis of pancreatic 
acini. That is, PKC-e is present in the apical region of 
acinar cells and PKC-~" is present on the luminal surfaces 
of acinar cells and of the ductular structures that extended 
from the acinar cells. Neither PKC-E nor PKC-~" is de- 
tectable in pancreatic islets. PKC-a and PKC-6 are de- 
D 
~•~i~ ~ ~i!  ¸ 
Fig. 5. Effects of CCK-8 and TPA on the immunostaining of PKC-~" in rat pancreatic acini. Pancreatic acini were incubated at 37°C for 10 min with no 
additions (A), 1 /zM TPA (B), 1 ;xM CCK-8 (C) or l/xM CCK-8 for l0 min and then 1 /xM L-364,718 for an additional 10 minutes (D). In panel A in 
control acini, there is staining of the luminal surface of occasional acinar cells. In panel B with TPA there is an increase in the number of acinar cells that 
show staining of the luminal surface. In panels C and D with CCK-8 alone or after adding L-364,718 the luminal staining of acinar cells is similar to that 
in panel A. In each panel magnification is ::< 400. 
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tectable in cells in the periphery of the islets but not in 
duct or acinar cells. The presence of PKC-a and PKC-S in 
our preparation of pancreatic acini is due to the islet cells 
that contaminate our preparation. As will be discussed 
later, the islet cells that contain PKC-ce probably differ 
from those that contain PKC-S. CCK-8 and TPA cause 
translocation of and enhance the immunostaining pattern 
of PKC-e and these effects of CCK-8 as well as the 
increase in DAG caused by CCK-8 can be reversed com- 
pletely by adding L-364,718. TPA, but not CCK-8, also 
causes translocation of PKC-~ and increases the number of 
acinar cells that showed immunostaining of PKC-~" over 
the luminal surface. 
Our finding PKC-t~ and PKC-3 in peripherally located 
cells in the islets agrees with previous reports by others 
[10-15]. One previous study [14] detected PKC-~" and 
PKC-e immunoreactivity in islet cells in rat pancreas; 
however, in the present study we found PKC-~" immuno- 
reactivity localized to the luminal surface of acinar cells 
and adjacent ductules and PKC-e immunoreactivity local- 
ized to acinar cells. This same previous study [14] also 
detected PKC-/3 immunoreactivity in islet cells. We de- 
tected no PKC-/3 immunoreactivity in pancreatic acini 
using quantitative immunoblot analysis [6] or in sections of 
whole pancreas or pancreatic acini using immunocyto- 
chemistry. The differences between the two studies in 
terms of PKC-/3 and the distribution of PKC-E and PKC-~" 
may reflect the use of different antisera because antisera 
that are satisfactory for immunoblot analysis may not be 
equally effective for immunocytochemistry. 
The present study was performed to attempt to explain 
the findings that although CCK-8 increases DAG in pan- 
creatic acini and causes translocation of PKC-S and PKC-e 
as would be expected, CCK-8 does not cause translocation 
of PKC-a or PKC-~. This lack of translocation of PKC-cz 
and PKC-~" does not result from an inability of these 
isoforms to undergo translocation because TPA can cause 
translocation of both isoforms. 
We were not surprised by the inability of CCK-8 to 
cause translocation of PKC-~" because this isoform lacks a 
phorbol ester binding site and is not activated by DAG 
[3,16-18]. PKC-~" can, however, be activated by phospha- 
tidylinositol 3,4,5-trisphosphate [19]. Since PKC-~" lacks a 
phorbol ester binding site and is not activated by DAG, we 
were initially surprised to find TPA-induced translocation 
of PKC-ff. Phorbol esters, however, have been found to 
cause translocation of PKC-~" in other systems [20,21]. It 
may be that, since activation of PKC is accompanied by 
autophosphorylation [22,23], TPA activation of some other 
isoform of PKC can phosphorylate PKC-ff; and thereby, 
induce its translocation. 
We considered several possible explanations for the 
inability of CCK-8 to cause translocation of PKC-a. One 
possibility is that CCK-8-induced translocation of PKC-a 
is transient and is reversed completely by the end of the 
incubation. Evidence for transient translocation of PKC-a 
is that in IIC9 fibroblasts incubated with thrombin, translo- 
cation of PKC-a is maximal by 15-30 s and reversed 
completely by 60 s [20]. In other experiments we made 
measurements as early as 15 s and failed to detect CCK-8- 
induced translocation of PKC-ct [6]. It is also possible that, 
although DAG can cause translocation of PKC-a, in our 
system the increase in cellular DAG is not in the proper 
functional compartment to cause translocation of PKC-a. 
In other systems [5,24-29] the increase in DAG derived 
from PIP 2 has been shown to cause translocation of PKC 
whereas the increase in DAG from phosphatidylcholine 
does not cause translocation of PKC. Others [20] have 
speculated that DAG derived from PIP 2 might have a 
different fatty acid composition from that derived from 
phosphatidylcholine and that these differences might ac- 
count for the different effects of DAG on an isoform of 
PKC. Finally, the present findings that PKC-a is found 
only in certain cells in the islets but not in acinar cells or 
duct cells support the hypothesis that CCK-8 does not 
cause translocation of PKC-c~ because the increase in 
DAG occurs in different cells (e.g., acinar cells) from the 
islet cells that contain PKC-c~. Presumably, this occurs 
because the islet cells that contain PKC-a do not possess 
receptors for CCK. 
PKC-& like PKC-a, is also present in islet cells, but 
not in acinar cells or duct cells. Unlike PKC-a, however, 
PKC-~ is translocated by CCK-8. Presumably this occurs 
because the islet cells that possess PKC-8 also possess 
CCK receptors that when occupied by CCK-8 cause in- 
creased DAG and translocation of PKC-tS. These islet 
cells, however, must be different from those that possess 
PKC-a. Support for this possibility is the finding that 
PKC-a is found only in /3 cells within the islets in rat 
pancreas, whereas other PKC isoforms occur in other cell 
types within the islets [13]. 
Finally, knowing that PKC-a and PKC-~ are in islet 
cells and not in acinar cells has practical consequences. 
That is, this information could lead investigators to explore 
other isoforms, such as PKC-e, instead of the a and 3 
isoforms as potential mediators of the actions of various 
agents on acinar cell function. 
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